EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Association of Body Mass Index and Paresthesia Symptoms with the Duration of Type 2 Diabetes Mellitus at Ardhito Medika Clinic, Bandar Lampung, 2025

Vio Salsabila, Festy Ladyani Mustofa, Muhammad Hatta, Raden Ayu Neilan Amroisa

Journal of Tropical Pharmacy and Chemistry · 31.07.2026 · 10 (2) · 25-33

DOI: 10.30872/jtpc.v10i2.418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Tropical Pharmacy and Chemistry, online erschienen am 31.07.2026. Verfasst von Vio Salsabila und 3 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic peripheral neuropathy is one of the most common chronic complications of type 2 diabetes mellitus (T2DM), with prolonged hyperglycemia and obesity recognized as major contributing factors. However, evidence regarding the relationship between body mass index (BMI), paresthesia, and diabetes duration among Indonesian patients remains limited. This study aimed to determine the association between BMI, paresthesia symptoms, and the duration of T2DM at Ardhito Medika Clinic, Bandar Lampung. A retrospective cross-sectional study was conducted using secondary data from electronic medical records of 62 patients with T2DM, including 31 patients with paresthesia and 31 without paresthesia. BMI was categorized as normal or overweight according to the WHO Asian classification, while diabetes duration was classified as ≤6 months or >6 months. Associations were analyzed using the Pearson chi-square test with odds ratios (ORs) and 95% confidence intervals (CIs). Paresthesia was significantly associated with diabetes duration (p < 0.001; OR = 4.145; 95% CI: 2.322–7.400). BMI was also significantly associated with diabetes duration (p = 0.020; OR = 3.500; 95% CI: 1.190–10.293). Longer diabetes duration was associated with paresthesia, whereas overweight BMI was associated with prolonged diabetes duration, highlighting the importance of early weight management and routine neuropathy screening.

Zitieren

APA

Salsabila, V., Mustofa, F. L., Hatta, M., & Amroisa, R. A. N. (2026). Association of Body Mass Index and Paresthesia Symptoms with the Duration of Type 2 Diabetes Mellitus at Ardhito Medika Clinic, Bandar Lampung, 2025. Journal of Tropical Pharmacy and Chemistry, 10(2), 25-33. https://doi.org/10.30872/jtpc.v10i2.418

Vancouver

Salsabila V, Mustofa FL, Hatta M, Amroisa RAN. Association of Body Mass Index and Paresthesia Symptoms with the Duration of Type 2 Diabetes Mellitus at Ardhito Medika Clinic, Bandar Lampung, 2025. Journal of Tropical Pharmacy and Chemistry. 2026;10(2):25-33. doi:10.30872/jtpc.v10i2.418

BibTeX
@article{Salsabila2026,
  author = {Salsabila, Vio and Mustofa, Festy Ladyani and Hatta, Muhammad and Amroisa, Raden Ayu Neilan},
  title = {Association of Body Mass Index and Paresthesia Symptoms with the Duration of Type 2 Diabetes Mellitus at Ardhito Medika Clinic, Bandar Lampung, 2025},
  journal = {Journal of Tropical Pharmacy and Chemistry},
  year = {2026},
  volume = {10},
  number = {2},
  pages = {25--33},
  doi = {10.30872/jtpc.v10i2.418}
}
Kostenlos starten →